Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19

Anticoagulant therapy is a cornerstone treatment for coronavirus disease 2019 (COVID-19) due to the high rates of thromboembolic complications associated with this disease. We hypothesized that chronic antithrombotic therapy could play a protective role in patients hospitalized for COVID-19. Retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrochano, Mariana, Acosta-Isaac, René, Mojal, Sergi, Miqueleiz, Sara, Rodriguez, Diana, Quijada-Manuitt, María Ángeles, Fraga, Edmundo, Castillo-Ocaña, Marta, Amaro-Hosey, Kristopher, Albiol, Nil, Soria, José Manuel, Antonijoan, Rosa Maria, Souto, Joan Carles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210515/
https://www.ncbi.nlm.nih.gov/pubmed/34138399
http://dx.doi.org/10.1007/s11239-021-02507-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210515/
https://www.ncbi.nlm.nih.gov/pubmed/34138399
http://dx.doi.org/10.1007/s11239-021-02507-2

Ejemplares similares